Astellas Austria

Last updated: 01.06.2015

Address: Linzerstraße 221/E02
1140 Wien,Austria

Tel: 01/877 26 68


Company description

In 2005, Astellas Pharma Ges.m.b.H. was founded after the merger of Fujisawa Ges.m.b.H.—formerly known as Klinge Pharma—with Yamanouchi. With its establishment, the company added Urology to its other key areas of therapeutic focus, which include Transplantation, Dermatology, Anti-infectives, Pneumology, and Pain Management. 2008 also marked the creation of a local Research & Development organisation—an important advance that will further strengthen the partnership we hold with our shareholders. This exciting development is also playing an essential role in our achievement of the goals set forth by VISION 2015.

Products and services

Astellas Pharma US is focused on providing safe and effective products that improve people’s lives.

Whether we are treating atopic dermatitis, fighting organ transplant rejection, helping patients exercise adequately, or treating an overactive bladder, we are committed to making a difference for our patients today and providing them with a brighter future tomorrow.

This commitment extends to providing resources for our patients and their physicians and caregivers that help them throughout the life cycle of their condition and beyond.

This section of our Web site provides information about our products, key resources for patients and healthcare professionals, and the details of our clinical trial policy and how to research Astellas’ ongoing clinical trials.



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here